Mark A. Socinski, MD
Alexander Drilon, MD
Keeping Pace: Advances in RET Fusion-Positive NSCLC
Sara Hurvitz, MD
Jacob Sands, MD
Clinical Considerations for Targeted Therapies Across Multiple Tumor Types
Helena Yu, MD
Keeping Pace: Advances in First-Line Therapy for EGFR-mutated NSCLC
John Healey, MD
William D. Tap, MD
A Multidisciplinary Approach to Treatment of Tenosynovial Giant Cell Tumor (T...
Gilberto de Lima Lopes Junior, MD, MBA, FAMS
Kai He, MD, PhD
Jyoti D. Patel, MD, FASCO
Keeping Pace with Immunotherapy Advances in Non-Small Cell Lung Cancer: Globa...
William J. Gradishar MD, FASCO, FACP
Peter Schmid, FRCP, MD, PhD
Perspectives for Clinical Practice: The Latest Advances for HER2-positive Met...
Keeping Pace: The Use of Immunotherapy in Mutation-Positive Non-Small Cell Lu...
Best Practices in the Treatment of Tenosynovial Giant Cell Tumor (TGCT)
Edward B. Garon, MD, MS
Keeping Pace: The Role of Immunotherapy After Disease Progression
Warner K. Huh, MD
Deborah K. Armstrong, MD
Robert L. Coleman, MD, FACOG, FACS
Keeping Pace in Women's Cancer: The Role of PARP Inhibitors in Ovarian Cancer
Suresh S. Ramalingam, MD
Keeping Pace: The Role of Immunotherapy in the Frontline Setting
Peter H. O'Donnell, MD
Daniel P. Petrylak, MD
Keeping Pace: Emerging Treatment Considerations in Metastatic Urothelial Cancer
Roy F. Chemaly, MD, MPH, FIDSA, FACP
Treating HCT Patients with CMV: A New Era of Therapy
C. Michael Gibson, MD, MS
Rod S. Passman, MD
Steven Steinbuhl, MD
Consumer Wearable Technology for AF Screening, Detection, and Management: Bol...
Miguel-Angel Perales, MD
Are You Failing Your HCT Recipients? A Case Study on CMV Prophylaxis
Stay current with the best on medical education
We’re glad to see you’re enjoying Prova Education…but how about a more personalized experience?
Press cancel to remain on Prova Education. Press the link below or the continue button to keep going.